A. Perrotta

发表

A selective phosphatase of regenerating liver phosphatase inhibitor suppresses tumor cell anchorage-independent growth by a novel mechanism involving p130Cas cleavage.

N. Fotouhi, D. Heimbrook, J. Reidhaar-Olson, 2008, Cancer research.

Microbial products. VI Five novel metabolites related to benz[a]anthracene from an unidentified actinomycete designated X-14881.

H. Maehr, J. Blount, J. Smallheer, 1982, The Journal of antibiotics.

Synthetic (S)-5-(benzoyloxy)-6-oxohexanoic acid ethyl ester and [S,S-(E)-3-(hydroxymethyl)oxiranebutanoic acid methyl ester, important synthons for leukotrienes B4 and A4, from D-arabinose

H. Maehr, J. Smallheer, A. Perrotta, 1988 .

Synthetic (S)-5-(Benzoyloxy)-6-oxohexanoic Acid Ethyl Ester and ((S,S)-E)-3-(Hydroxymethyl)oxiranebutanoic Acid Methyl Ester, Important Synthons for Leukotrienes B4 and A4, from D-Arabinose.

H. Maehr, J. Smallheer, A. Perrotta, 1988 .

Syntheses of antibacterial 2,4-diamino-5-benzylpyrimidines. Ormetoprim and trimethoprim

P. Manchand, P. Rosen, A. Perrotta, 1992 .

Nitration Studies on 2-Isopropylimidazole

R. S. Glass, J. Blount, D. Butler, 1972 .

Structural determination of ascorbic acid 2-o-phosphate formed via acid hydrolysis of an ascorbic acid 3-O-phosphinate

J. Blount, V. Toome, P. Rosen, 1979 .

Microbial products. VII. The relative configuration of actinomycete metabolite X-14881D.

H. Maehr, R. Pitcher, J. Blount, 1985, The Journal of antibiotics.

Peptide and peptide mimetic inhibitors of antigen presentation by HLA-DR class II MHC molecules. Design, structure-activity relationships, and X-ray crystal structures.

R Crowther, U. Kammlott, J. Guenot, 2000, Journal of medicinal chemistry.